EcoR1 Capital LLC 13D/13G Filings for Ovid Therapeutics Inc. (OVID)

EcoR1 Capital LLC 13D and 13G filings for Ovid Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-14
6:01 pm
Sale		 2024-09-30 13G Ovid Therapeutics Inc.
OVID		 EcoR1 Capital LLC 0
0.000%		 -6,117,400decrease
(Position Closed)		 Filing
2023-02-10
2:28 pm
Purchase		 2022-12-31 13G Ovid Therapeutics Inc.
OVID		 EcoR1 Capital LLC 6,117,400
8.700%		 35,200increase
(+0.58%)		 Filing
2022-02-14
3:21 pm
Purchase		 2021-12-31 13G Ovid Therapeutics Inc.
OVID		 EcoR1 Capital LLC 6,082,200
8.900%		 6,082,200increase
(New Position)		 Filing